| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |